Terms: = Endocrine gland cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel
47 results:
1. Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score-matching study (with videos).
Song YJ; Huh G; Kim EH; Lee JB; Park DH
Gastrointest Endosc; 2023 Oct; 98(4):585-596.e3. PubMed ID: 37211286
[TBL] [Abstract] [Full Text] [Related]
2. Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.
Kindler HL; Yoo HK; Hettle R; Cui KY; Joo S; Locker GY; Golan T
Cancer; 2023 May; 129(9):1411-1418. PubMed ID: 36811344
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Ramanathan S; Prasad M; Vora T; Badira CP; Kembhavi S; Ramadwar M; Khanna N; Laskar S; Muckaden MA; Qureshi S; Banavali S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Apr; 70(4):e30179. PubMed ID: 36645132
[TBL] [Abstract] [Full Text] [Related]
4. Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
Zhu C; Sandilos G; Williamson J; Emery R; Platoff R; Joneja U; Acharya NK; Lin A; Badach J; Zilberman B; Madzo J; Jelinek J; Zhang P; Hong YK
Surgery; 2023 Apr; 173(4):1045-1051. PubMed ID: 36642656
[TBL] [Abstract] [Full Text] [Related]
5. Who really benefits from intraperitoneal chemotherapy for advanced ovarian cancer? A treatment-free survival analysis of the AICE trial.
Xiang L; Shen L; Chen Y; Guo Y; Jiang R; Zhang W; Jia H; Wu Z; Zang R
BJOG; 2022 Nov; 129 Suppl 2():32-39. PubMed ID: 36485070
[TBL] [Abstract] [Full Text] [Related]
6. METTL3 restrains papillary thyroid cancer progression via m
He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
[TBL] [Abstract] [Full Text] [Related]
7. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
[TBL] [Abstract] [Full Text] [Related]
8. Multiparametric MRI Evaluation of Complex Ovarian Masses.
Singla V; Dawadi K; Singh T; Prabhakar N; Srinivasan R; Suri V; Khandelwal N
Curr Probl Diagn Radiol; 2021; 50(1):34-40. PubMed ID: 31399230
[TBL] [Abstract] [Full Text] [Related]
9. Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
Konczalla L; Perez DR; Wenzel N; Wolters-Eisfeld G; Klemp C; Lüddeke J; Wolski A; Landschulze D; Meier C; Buchholz A; Yao D; Hofmann BT; Graß JK; Spriestersbach SL; Grupp K; Schumacher U; Betzel C; Kapis S; Nuguid T; Steinberg P; Püschel K; Sauter G; Bockhorn M; Uzunoglu FG; Izbicki JR; Güngör C; El Gammal AT
Int J Cancer; 2020 Mar; 146(6):1618-1630. PubMed ID: 31291468
[TBL] [Abstract] [Full Text] [Related]
10. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-365a-3p inhibits c-rel-mediated NF-κB signaling and the progression of pancreatic cancer.
Yin L; Xiao X; Georgikou C; Yin Y; Liu L; Karakhanova S; Luo Y; Gladkich J; Fellenberg J; Sticht C; Gretz N; Gross W; Herr I
Cancer Lett; 2019 Jun; 452():203-212. PubMed ID: 30910589
[TBL] [Abstract] [Full Text] [Related]
12. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
[TBL] [Abstract] [Full Text] [Related]
13. Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
Lutgendorf SK; Thaker PH; Arevalo JM; Goodheart MJ; Slavich GM; Sood AK; Cole SW
Cancer; 2018 Feb; 124(3):580-586. PubMed ID: 29112229
[TBL] [Abstract] [Full Text] [Related]
14. Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
Pelzer U; Blanc JF; Melisi D; Cubillo A; Von Hoff DD; Wang-Gillam A; Chen LT; Siveke JT; Wan Y; Solem CT; Botteman MF; Yang Y; de Jong FA; Hubner RA
Br J Cancer; 2017 May; 116(10):1247-1253. PubMed ID: 28350787
[TBL] [Abstract] [Full Text] [Related]
15. NF-κB1, c-rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer.
Shuang T; Wang M; Zhou Y; Shi C; Wang D
Oncotarget; 2017 Apr; 8(15):24853-24868. PubMed ID: 28206956
[TBL] [Abstract] [Full Text] [Related]
16. Allergen-Removed Rhus verniciflua Extract Induces Ovarian cancer Cell Death via JNK Activation.
Kang SH; Hwang IH; Son E; Cho CK; Choi JS; Park SJ; Jang BC; Lee KB; Lee ZW; Lee JH; Yoo HS; Jang IS
Am J Chin Med; 2016; 44(8):1719-1735. PubMed ID: 27848251
[TBL] [Abstract] [Full Text] [Related]
17. Over-expression of nuclear NF-κB1 and c-rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer.
Shuang T; Wang M; Zhou Y; Shi C
Exp Mol Pathol; 2016 Feb; 100(1):139-44. PubMed ID: 26683819
[TBL] [Abstract] [Full Text] [Related]
18. c-rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
[TBL] [Abstract] [Full Text] [Related]
19. Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.
Reni M; Wan Y; Solem C; Whiting S; Ji X; Botteman M
J Med Econ; 2014 May; 17(5):338-46. PubMed ID: 24654922
[TBL] [Abstract] [Full Text] [Related]
20. Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.
Bernardin L; Dilks P; Liyanage S; Miquel ME; Sahdev A; Rockall A
Eur Radiol; 2012 Apr; 22(4):880-90. PubMed ID: 22095438
[TBL] [Abstract] [Full Text] [Related]
[Next]
